Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 2
2016 4
2017 8
2018 3
2019 3
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

18 results
Results by year
Filters applied: . Clear all
Page 1
Role of Galectins in Multiple Myeloma.
Storti P, Marchica V, Giuliani N. Storti P, et al. Among authors: Marchica V. Int J Mol Sci. 2017 Dec 17;18(12):2740. doi: 10.3390/ijms18122740. Int J Mol Sci. 2017. PMID: 29258207 Free PMC article. Review.
ILF2 Is a Regulator of RNA Splicing and DNA Damage Response in 1q21-Amplified Multiple Myeloma.
Marchesini M, Ogoti Y, Fiorini E, Aktas Samur A, Nezi L, D'Anca M, Storti P, Samur MK, Ganan-Gomez I, Fulciniti MT, Mistry N, Jiang S, Bao N, Marchica V, Neri A, Bueso-Ramos C, Wu CJ, Zhang L, Liang H, Peng X, Giuliani N, Draetta G, Clise-Dwyer K, Kantarjian H, Munshi N, Orlowski R, Garcia-Manero G, DePinho RA, Colla S. Marchesini M, et al. Among authors: Marchica V. Cancer Cell. 2017 Jul 10;32(1):88-100.e6. doi: 10.1016/j.ccell.2017.05.011. Epub 2017 Jun 29. Cancer Cell. 2017. PMID: 28669490 Free PMC article.
The transcriptomic profile of CD138+ cells from patients with early progression from smoldering to active multiple myeloma remains substantially unchanged.
Storti P, Agnelli L, Palma BD, Todoerti K, Marchica V, Accardi F, Sammarelli G, Deluca F, Toscani D, Costa F, Vicario E, Todaro G, Martella E, Neri A, Giuliani N. Storti P, et al. Among authors: Marchica V. Haematologica. 2019 Oct;104(10):e465-e469. doi: 10.3324/haematol.2018.209999. Epub 2019 Mar 7. Haematologica. 2019. PMID: 30846495 Free PMC article. Clinical Trial. No abstract available.
Dependence on glutamine uptake and glutamine addiction characterize myeloma cells: a new attractive target.
Bolzoni M, Chiu M, Accardi F, Vescovini R, Airoldi I, Storti P, Todoerti K, Agnelli L, Missale G, Andreoli R, Bianchi MG, Allegri M, Barilli A, Nicolini F, Cavalli A, Costa F, Marchica V, Toscani D, Mancini C, Martella E, Dall'Asta V, Donofrio G, Aversa F, Bussolati O, Giuliani N. Bolzoni M, et al. Among authors: Marchica V. Blood. 2016 Aug 4;128(5):667-79. doi: 10.1182/blood-2016-01-690743. Epub 2016 Jun 6. Blood. 2016. PMID: 27268090 Free article.
Bone Marrow CX3CL1/Fractalkine is a New Player of the Pro-Angiogenic Microenvironment in Multiple Myeloma Patients.
Marchica V, Toscani D, Corcione A, Bolzoni M, Storti P, Vescovini R, Ferretti E, Dalla Palma B, Vicario E, Accardi F, Mancini C, Martella E, Ribatti D, Vacca A, Pistoia V, Giuliani N. Marchica V, et al. Cancers (Basel). 2019 Mar 6;11(3):321. doi: 10.3390/cancers11030321. Cancers (Basel). 2019. PMID: 30845779 Free PMC article.
Possible targets to treat myeloma-related osteoclastogenesis.
Bolzoni M, Toscani D, Storti P, Marchica V, Costa F, Giuliani N. Bolzoni M, et al. Among authors: Marchica V. Expert Rev Hematol. 2018 Apr;11(4):325-336. doi: 10.1080/17474086.2018.1447921. Epub 2018 Mar 9. Expert Rev Hematol. 2018. PMID: 29495905 Review.
Neurofibromatosis type I and multiple myeloma coexistence: A possible link?
Accardi F, Marchica V, Mancini C, Maredi E, Racano C, Notarfranchi L, Martorana D, Storti P, Martella E, Palma BD, Craviotto L, Filippo M, Percesepe A, Aversa F, Giuliani N. Accardi F, et al. Among authors: Marchica V. Hematol Rep. 2018 Apr 3;10(1):7457. doi: 10.4081/hr.2018.7457. eCollection 2018 Mar 2. Hematol Rep. 2018. PMID: 29721253 Free PMC article.
Bone marrow Dikkopf-1 levels are a new independent risk factor for progression in patients with smouldering myeloma.
Dalla Palma B, Marchica V, Pedrazzoni M, Accardi F, Notarfranchi L, Goldoni M, De Luca F, Costa F, Storti P, Toscani D, Sammarelli G, Bonomini S, Aversa F, Giuliani N. Dalla Palma B, et al. Among authors: Marchica V. Br J Haematol. 2018 Dec;183(5):812-815. doi: 10.1111/bjh.15026. Epub 2017 Nov 16. Br J Haematol. 2018. PMID: 29143308 No abstract available.
Novel targets for the treatment of relapsing multiple myeloma.
Giuliani N, Accardi F, Marchica V, Dalla Palma B, Storti P, Toscani D, Vicario E, Malavasi F. Giuliani N, et al. Among authors: Marchica V. Expert Rev Hematol. 2019 Jul;12(7):481-496. doi: 10.1080/17474086.2019.1624158. Epub 2019 Jun 3. Expert Rev Hematol. 2019. PMID: 31125526 Review.
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts.
Bolzoni M, Ronchetti D, Storti P, Donofrio G, Marchica V, Costa F, Agnelli L, Toscani D, Vescovini R, Todoerti K, Bonomini S, Sammarelli G, Vecchi A, Guasco D, Accardi F, Palma BD, Gamberi B, Ferrari C, Neri A, Aversa F, Giuliani N. Bolzoni M, et al. Among authors: Marchica V. Haematologica. 2017 Apr;102(4):773-784. doi: 10.3324/haematol.2016.153841. Epub 2017 Jan 5. Haematologica. 2017. PMID: 28057743 Free PMC article.
18 results
Jump to page
Feedback